--- title: CDMOs offering Oral Solid Dosage Manufacturing with Small Molecule path: /explore/oral-solid-dosage/small-molecule companies_count: 38 --- # CDMOs offering Oral Solid Dosage Manufacturing with Small Molecule 38 published CDMOs match Oral Solid Dosage Manufacturing and Small Molecule. Locations in this set include United States, Germany, India, United Kingdom, Canada, and France. Capabilities that show up most often in this set: Formulation Development, Process Development, Quality Control Testing, CMC Analytical Development, and Technology Transfer. ## Matching companies - [AbbVie Contract Manufacturing](/companies/abbviecontractmfg) - Global CMO offering small and large molecule drug substance to drug product manufacturing, with specialized capabilities in antibody drug conjugates, aseptic fill-finish, biologics (mAbs), HPAPI, and eye care across 12 facilities in the US and Europe. - [Adragos Pharma](/companies/adragos-pharma) - Global CDMO headquartered in Munich offering end-to-end development and manufacturing for small molecules and biologics, including sterile/non-sterile liquids, solids, semi-solids, lyophilization, and prefilled syringes across seven facilities in Europe and Japan. - [Aenova Group](/companies/aenova-group) - Aenova Group is a worldwide leading contract manufacturer for the pharmaceutical and healthcare industry, offering solid dosage, sterile, semi-solid, and softgel manufacturing across multiple European and North American facilities. - [Akums Drugs and Pharmaceuticals Ltd.](/companies/akums) - India's largest CDMO with 15+ state-of-the-art facilities and 30% domestic market share, manufacturing 4,100+ formulations across tablets, capsules, injectables, APIs, and specialty dosage forms under WHO-GMP, USFDA, EU-GMP, and TGA compliance. - [Almac Group](/companies/almacgroup) - Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities. - [Amneal Pharmaceuticals](/companies/amneal-pharmaceutical) - U.S.-based biopharmaceutical company offering oral solid dosage, injectables, and API manufacturing with FDA-approved facilities across the U.S. and India, including advanced capabilities in lyophilization, aseptic processing, and oncology formulations. - [Applied Pharmaceutical Innovation](/companies/appliedpharma) - Edmonton-based not-for-profit offering integrated CDMO services in sterile fill-finish, oral solid dosage, topical application, and highly potent controlled substance manufacturing. Also provides CRO research, regulatory and quality, and clinical and quantitative support. - [Ardena](/companies/ardena) - Ardena is an integrated CDMO and bioanalytical CRO specializing in advanced drug product development, nanomedicine, and bioanalysis for complex molecules including poorly soluble compounds, highly potent APIs, and controlled substances. - [Ascendia Pharmaceutical Solutions](/companies/ascendiacdmo) - Ascendia is a specialty CDMO providing formulation development, analytical services, and GMP manufacturing for small molecules and biologics from pre-formulation through commercialization, with proprietary nanotechnologies including LipidSol, EmulSol, AmorSol, and NanoSol. - [Asymchem Laboratories](/companies/asymchem) - Asymchem is a CDMO providing integrated API synthesis, drug product development, and biologics manufacturing with specialized capabilities in peptides, oligonucleotides, highly potent compounds, and flow chemistry. - [AustinPx](/companies/austinpx) - Fee-for-service CDMO specializing in formulation development, process development, and GMP manufacturing of oral dosage forms from preclinical through Phase II, with proprietary KinetiSol amorphous solid dispersion technology for poorly soluble APIs. - [BSP Pharmaceuticals](/companies/bsppharmaceuticals) - BSP Pharmaceuticals is a CDMO specializing in development and manufacturing of cytotoxic oncology drugs, ADCs, peptides, proteins, and lipid-based formulations from preclinical GLP through commercial supply. - [Bend Bioscience](/companies/bend-bioscience) - U.S. pharmaceutical CDMO offering design, development, and manufacturing of oral solid and liquid dosage forms, from early formulation to commercial-scale production across three domestic locations. - [Burrard Pharmaceuticals](/companies/burrardpharma) - Vancouver-based CDMO delivering technology transfer, formulation development, and GMP manufacturing for 75+ molecules across oncology, diabetes, and respiratory therapeutics since 2005. - [Bushu Pharmaceuticals](/companies/bushu-pharma) - Bushu Pharmaceuticals is a contract development and manufacturing organization (CDMO) specializing in pharmaceutical contract manufacturing with over 25 years of experience. - [Catalent](/companies/catalent) - Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply. - [Codis](/companies/codis) - Global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions, microencapsulation, and continuous granulation with 400,000 sq ft of GMP manufacturing across US and UK facilities. - [Confab](/companies/confab) - Confab is a recognized CDMO offering contract manufacturing, formulation development, technology transfer, and analytical services for prescription, over-the-counter, generic, controlled, and veterinary pharmaceuticals across liquid, solid, and semi-solid dosage forms. - [CordenPharma](/companies/cordenpharma) - Full-service CDMO offering cGMP development and manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligonucleotides, and oral solid dose across 10 facilities in 6 countries with 3000+ employees. - [Delpharm](/companies/delpharm) - Top-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually.